News & Events

In this section

Instem Announces Global Partnership Agreement with SAS in Life Sciences

Collaboration Enhances Customer Experience While Increasing Capabilities

CONSHOHOCKEN, PA - (BUSINESS WIRE) – August 19, 2010 - - Instem, a leading provider of early drug development software solutions, announced today it has signed a global partnership agreement with SAS, the leader in business analytics software and services. The partnering arrangement enables Instem to more cost effectively license its clients directly for SAS® technology embedded within its Provantis® preclinical software suite. This will streamline deployment processes and reduce costs for clients, especially for laboratories with smaller numbers of users.

Instem’s Provantis solution uses SAS as one of the underlying technologies in its Tables and Statistics module. This market-leading product generates tables and performs statistical analysis on data collected by other products in the Provantis suite. Users can run descriptive or comparative statistics, which are definable by parameter or table, and can be selected at run-time, using easy-to-navigate Provantis functionality.

SAS technology provides Instem customers a range of techniques and processes for the analysis and interpretation of data to reveal patterns, anomalies, key variables and relationships - ultimately leading to new insights and better answers faster.

“This is a terrific partnership for Instem and another big win for our clients,” states Gary Mitchell, VP of Global Marketing at Instem. “We have been working with SAS very closely to develop a new and exclusive model for our Provantis clients. This reduces their overall cost of Provantis while streamlining the deployment process for both hosted and traditional on-site installations.”

Instem, now a SAS Gold Application Partner, additionally has access to ongoing value-added resources in the areas of training, marketing, strategic planning and technical services at SAS offices worldwide.

Instem help desk personnel will directly support new clients while the technical services team will be empowered to install and maintain all SAS technologies within the Instem delivery framework.

“Partnering with Instem, leaders in preclinical IT with deep domain expertise, allows SAS to expand and better serve a critical segment of the scientific community,” states Kecia Serwin, SAS General Manager of Health and Life Sciences. “We are looking forward to partnering with Instem as they bring new solutions to market, specifically in the area of knowledge management.”

In support of new solution development efforts, Mark Wolff, SAS Health and Life Sciences Solutions Architect, presented at Instem’s 2010 international user’s conference in Chicago. Wolff delivered a powerful speech on the challenges facing today’s progressive pharmaceutical R&D community. According to Wolff,  “those challenges will be the efficient collection, processing and analysis of vast amounts of disparate research data and the development of facile access points along the R&D process that provide scientists and business decision makers with actionable information. Data-driven insights will serve to manage and direct the future of a compound from discovery to commercialization, and to understand and rationalize post-marketing safety, efficacy and health economics issues.”

The choice of 100 percent of the FORTUNE Global 500® life sciences companies, SAS is globally recognized as the industry leader in business analytics and the de facto standard for clinical data analysis and reporting. By partnering with Instem, SAS will be able to increase its footprint within the preclinical segment of life sciences through Instem’s integrated Provantis software solution.

About Provantis®

Provantis is a modern, fully integrated software system for single users and global organizations engaged in preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.

Since the release of Provantis Version 8, Instem introduced a new open architecture concept to the Tables and Statistics product. The open architecture frees the user from the complexities of a database, presenting the data in a simple, industry-standard XML file and easily formatting the data onto the report page.

About SAS

SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions delivered within an integrated framework, SAS helps customers at more than 45,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world The Power to Know®.

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Gary Mitchell (US HQ)
Tel: 610-941-0990

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600